Acrodermatitis chronica atrophicans overview: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
{{ACA}} | {{ACA}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== |
Revision as of 17:46, 4 December 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Acrodermatitis chronica atrophicans Microchapters |
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Acrodermatitis chronica atrophicans overview On the Web |
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans overview |
Risk calculators and risk factors for Acrodermatitis chronica atrophicans overview |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Acrodermatitis chronica atrophicans is a skin rash indicative of the third or late stage of European Lyme borreliosis. It is a dermatological condition that takes a chronically progressive course and finally leads to a widespread atrophy of the skin. Involvement of the peripheral nervous system is often observed, specifically polyneuropathy.